Aclaris Therapeutics

Request correction

Corporate brand

Unclaimed Read 2× by AI crawlers

A biopharmaceutical company focused on developing therapies for immuno-inflammatory conditions.

Last updated September 1, 2026

AI crawler reads

2requests

1companies

Anthropic2

Profile: 2
Controversies: 0
JSON · MD: 0

First read: Nov 4, 2026
Latest read: Nov 4, 2026

From this site's server log

Overview

Aclaris Therapeutics is a biopharmaceutical company that strives to translate scientific discovery into everyday victories in immuno-inflammatory conditions. It focuses on leveraging core expertise in drug discovery and development and kinase inhibition to develop novel small and large molecule drugs for underserved immuno-inflammatory conditions. The company also operates Confluence Discovery Technologies, Inc., a full-service drug discovery and early development contract research organization.

History

Aclaris Therapeutics is a biopharmaceutical company focused on immuno-inflammatory conditions. It uses the proprietary KINect technology platform for kinome innovation and develops kinase inhibitors and biologic product candidates. It operates Confluence Discovery Technologies, Inc., a contract research organization.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/aclaris-therapeutics · Editorial policy · How profiles are compiled